Trial Profile
Acute and subchronic effects of bilastine (20 and 40mg) and hydroxyzine (50mg) on actual driving performance in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jan 2012
Price :
$35
*
At a glance
- Drugs Bilastine (Primary) ; Hydroxyzine (Primary)
- Indications Allergic rhinitis; Rhinoconjunctivitis
- Focus Pharmacodynamics
- 18 Jan 2012 New trial record